Clinical Trials
8 trialsNCT05976555 2026-05-20
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
Medical College of Wisconsin
Phase 1 Not yet recruiting
NCT03663218 2026-03-18
PREPARE SBRT
Weill Medical College of Cornell University
Phase NA Active not recruiting
NCT05212012 2025-10-03
MEFOX
AIO-Studien-gGmbH
Phase 1/2 Active not recruiting
NCT03838367 2025-09-09
Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
CytoDyn, Inc.
Phase 1/2 Terminated
NCT06976892 2025-08-13
IDOL
Institute of Cancer Research, United Kingdom
Phase 1 Recruiting
NCT02994953 2024-09-20
COMBO
EMD Serono
Phase 1 Terminated
NCT02477215 2020-10-22
Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma
Medical College of Wisconsin
Phase 1/2 Completed
NCT01647711 2017-01-31
A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations
Boehringer Ingelheim
Phase 1 Completed